Telogen effluvium revisited.
February 2014
in “PubMed”
TLDR Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.
The 2014 review "Telogen effluvium revisited" discussed Telogen effluvium (TE), a heterogeneous hair loss disorder. TE was classified into three main categories: premature teloptosis, collective teloptosis, and premature entry into telogen. The latter could be further divided into drug-induced TE, TE due to dietary deficiencies, and "autoimmune" TE. The majority of TE cases observed by dermatologists were of the autoimmune type. The typical patient was a woman in good health, who had been in an anxious state for some months and experienced sudden hair loss. The course of the disorder was chronic but intermittent, with irregular remissions and relapses. The shed hairs mostly exhibited exogen roots, not telogen ones. This type of TE shared similarities with alopecia areata, including the triggering role of emotional stress and the frequent association with Hashimoto's thyroiditis. In the absence of a documented etiopathogenesis, no treatment could be endorsed, but a course of topical corticosteroids could be tried.
View this study on pubmed.ncbi.nlm.nih.gov →
Related
research Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
research A clinico-epidemiological study of scalp hair loss in children (0–18 years) in Kota Region, South-East Rajasthan
About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.
research Hair disorders
The document's conclusion cannot be provided because the document cannot be parsed.
research Topical and intralesional therapies for alopecia areata
No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.
research Hair Diseases (Alopecia Areata and Androgenetic Alopecia)
Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.